Publication & Citation Trends
Most Cited Works
Publications
22 total
Safety and efficacy of autologous CAR T cells targeting GD2 (GD2-CART01) in patients with high-risk metastatic, relapsed, or refractory neuroblastoma: updated analysis (was selected for ORAL presentation)
Cited by 0
Semantic Scholar
CD19 antigen: From tumor target to safety switch able to improve the safety profile of CAR T cell therapy
Cited by 0
Semantic Scholar
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial
Cited by 26
Semantic Scholar
A novel B7-H3-specific binder enables effective CAR T-cell therapy in an Acute Myeloid Leukemia experimental model
Cited by 0
Semantic Scholar
Truncated form of human CD19 antigen as a suicide gene to control T-cell alloreactivity: ∆CD19
Cited by 0
Semantic Scholar
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
Cited by 27
Semantic Scholar
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma OA
Cited by 30
Semantic Scholar
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study OA
Cited by 3
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(14)
T-cell and B-cell Immunology
(12)
Immune Cell Function and Interaction
(10)
Monoclonal and Polyclonal Antibodies Research
(5)
vaccines and immunoinformatics approaches
(4)
Frequent Co-Authors
Affiliations
Johns Hopkins University
Torrey Pines Institute For Molecular Studies
Autoimmune Technologies (United States)
Epic Sciences (United States)
Cytel (United States)